Different studies using phosphomimetic mutations (S13D/S16D) or Httex1-like peptides showed that phosphorylation at both residues (pSer-13/pSer-16) influence the aggregation of Httex1 and reverses Htt's pathology in an HD mouse model (23, 31, 32). Here, HTT is linked to Huntington disease.